{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T16:56:49Z","timestamp":1778000209163,"version":"3.51.4"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T00:00:00Z","timestamp":1681257600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p><jats:bold>Objective:<\/jats:bold> Although <jats:italic>Xiaoyao-san<\/jats:italic> (XYS) is a popular herbal remedy for indigestion, there is insufficient evidence to recommend it as a treatment option for functional dyspepsia (FD). This review aimed to assess the safety and efficacy of XYS in patients with FD, compared to conventional Western medicine (WM).<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> Two independent reviewers searched for randomized controlled trials (RCTs) using 11 electronic databases, including Medline and Embase, to evaluate therapeutic effects of XYS on FD up to 31 January 2023. The primary outcome was the total clinical efficacy rate (TCE), and secondary outcomes included scores of dyspepsia-related symptoms (DSS) and incidence of adverse events (AEs). The risk of bias was evaluated using the Cochrane collaboration tool, and data synthesis and subgroup analyses were performed using the Review Manager program.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Six studies involving 707 participants were included in the meta-analysis. XYS significantly improved TCE compared to WM (RR = 1.15, 95% CI: 1.05, 1.26, <jats:italic>p<\/jats:italic> = 0.002) with high heterogeneity (<jats:italic>I<\/jats:italic><jats:sup><jats:italic>2<\/jats:italic><\/jats:sup> = 59%, <jats:italic>p<\/jats:italic> = 0.06). Combination therapy also showed higher TCE than WM alone (RR = 1.22, 95% CI: 1.05, 1.41, <jats:italic>p<\/jats:italic> = 0.008), and the heterogeneity was low (<jats:italic>I<\/jats:italic><jats:sup><jats:italic>2<\/jats:italic><\/jats:sup> = 0%, <jats:italic>p<\/jats:italic> = 0.86). The results showed a greater reduction in DSS in the XYS and combination therapy groups than in the WM alone group (SMD = \u22120.72, 95% CI: \u22120.90, \u22120.53, <jats:italic>p<\/jats:italic> &amp;lt; 0.00001) with low heterogeneity (<jats:italic>I<\/jats:italic><jats:sup><jats:italic>2<\/jats:italic><\/jats:sup> = 44%, <jats:italic>p<\/jats:italic> = 0.15), especially for abdominal distension and upper abdominal pain. AEs occurred less frequently in the XYS and combination therapy groups than in the WM alone group (RR = 0.20, 95% CI: 0.07, 0.63, <jats:italic>p<\/jats:italic> = 0.006), and the heterogeneity was low (<jats:italic>I<\/jats:italic><jats:sup><jats:italic>2<\/jats:italic><\/jats:sup> = 45%, <jats:italic>p<\/jats:italic> = 0.18). The certainty of the evidence for each outcome was rated from \u201cvery low\u201d to \u201chigh.\u201d<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> This review suggests that XYS is effective and safe for reducing complaints in patients with FD. However, high-quality RCTs should be conducted to establish more convincing therapeutic evidence of XYS for the treatment of FD.<\/jats:p><jats:p><jats:bold>Systematic Review Registration:<\/jats:bold><jats:ext-link>https:\/\/www.crd.york.ac.uk\/prospero<\/jats:ext-link>, CRD42020178842<\/jats:p>","DOI":"10.3389\/fphar.2023.1114222","type":"journal-article","created":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T05:54:06Z","timestamp":1681278846000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Safety and efficacy of Xiaoyao-san for the treatment of functional dyspepsia: a systematic review and meta-analysis of randomized controlled trials"],"prefix":"10.3389","volume":"14","author":[{"given":"Na-Yeon","family":"Ha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanul","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haein","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seok-Jae","family":"Ko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae-Woo","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinsung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,4,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1111\/j.1365-2036.2005.02572.x","article-title":"Validation of the gastrointestinal symptom score for the assessment of symptoms in patients with functional dyspepsia","volume":"22","author":"Adam","year":"2005","journal-title":"Aliment. Pharmacol. Ther."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1016\/j.jep.2011.07.053","article-title":"Prescription patterns of Chinese herbal products for menopausal syndrome: Analysis of a nationwide prescription database","volume":"137","author":"Chen","year":"2011","journal-title":"J. Ethnopharmacol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1177\/2050640617724061","article-title":"Complementary and alternative treatment in functional dyspepsia","volume":"6","author":"Chiarioni","year":"2018","journal-title":"United Eur. Gastroenterol. J."},{"key":"B4","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.jep.2010.01.016","article-title":"Metabolomics study on the anti-depression effect of xiaoyaosan on rat model of chronic unpredictable mild stress","volume":"128","author":"Dai","year":"2010","journal-title":"J. Ethnopharmacol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1136\/gutjnl-2014-307843","article-title":"Global prevalence of, and risk factors for, uninvestigated dyspepsia: A meta-analysis","volume":"64","author":"Ford","year":"2015","journal-title":"Gut"},{"key":"B6","doi-asserted-by":"publisher","first-page":"367","DOI":"10.5056\/jnm18071","article-title":"Role of gut microbiota-gut hormone axis in the pathophysiology of functional gastrointestinal disorders","volume":"24","author":"Fukui","year":"2018","journal-title":"J. Neurogastroenterol. Motil."},{"key":"B7","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1111\/j.1572-0241.2004.04046.x","article-title":"Alternative medicine use by Canadian ambulatory gastroenterology patients: Secular trend or epidemic?","volume":"99","author":"Ganguli","year":"2004","journal-title":"Am. J. Gastroenterol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/jebm.12018","article-title":"Understanding GRADE: An introduction","volume":"6","author":"Goldet","year":"2013","journal-title":"J. Evid. Based. Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"e22359","DOI":"10.1097\/md.0000000000022359","article-title":"Safety and efficacy of soyo-san for the treatment of functional dyspepsia: A protocol for systematic review and meta-analysis","volume":"99","author":"Ha","year":"2020","journal-title":"Med. Baltim."},{"key":"B10","volume-title":"Cochrane handbook for systematic reviews of interventions","author":"Higgins","year":"2022"},{"key":"B11","doi-asserted-by":"publisher","first-page":"114612","DOI":"10.1016\/j.jep.2021.114612","article-title":"Xiaoyao San attenuates hepatic steatosis through estrogen receptor \u03b1 pathway in ovariectomized ApoE\u2212\/\u2212 mice","volume":"282","author":"Hu","year":"2022","journal-title":"J. Ethnopharmacol."},{"key":"B12","first-page":"337","article-title":"Relation between syndrome type, electrogastrography and stomachoscopy of stomachache and the effect of Xiaoyao Powder","author":"Huang","year":"1992","journal-title":"Shaanxi J. Tradit. Chin. Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/nbt.3167","article-title":"A systems approach to traditional oriental medicine","volume":"33","author":"Kim","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"209","DOI":"10.14374\/HFS.2017.25.2.209","article-title":"Consideration in the interpretation of the Soyo-san prescription","volume":"25","author":"Lee","year":"2017","journal-title":"Herb. Formula Sci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1440-1746.2006.04196.x","article-title":"Development and validation of a functional dyspepsia\u2010related quality of life (FD\u2010QOL) scale in South Korea","volume":"21","author":"Lee","year":"2006","journal-title":"J. Gastroenterol. Hepatol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"100706","DOI":"10.1016\/j.imr.2020.100706","article-title":"Prescription patterns of herbal medicine for menopausal disorders in major Korean medicine hospitals: A multicenter retrospective study","volume":"10","author":"Lee","year":"2021","journal-title":"Integr. Med. Res."},{"key":"B17","first-page":"48","article-title":"Observation of curative effect on peri-menopausal patients with functional dyspepsia treated by modified Danzhi Xiaoyao Powder combined with Livial","volume":"8","author":"Li","year":"2006","journal-title":"J. Hubei Coll. Trad. Chin. Med."},{"key":"B18","volume-title":"Clinical study of modified Xiao Yao power combined with livial on menopausal patients with functional dyspepsia","author":"Li","year":"2006"},{"key":"B19","doi-asserted-by":"publisher","first-page":"458","DOI":"10.13633\/j.cnki.zjtcm.2017.06.051","article-title":"Treatment of 60 cases of functional dyspepsia with liver stagnation and spleen deficiency combined with traditional Chinese medicine and western medicine","volume":"52","author":"Liu","year":"2017","journal-title":"Zhejiang J. Trad. Chin. Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.jtcms.2017.09.005","article-title":"Effect of Xiaoyao San on the brain-gut axis in rats after chronic immobilization stress","volume":"4","author":"Liu","year":"2017","journal-title":"J. Trad. Chin. Med. Sci."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1016\/j.cgh.2015.03.032","article-title":"Acute anxiety and anxiety disorders are associated with impaired gastric accommodation in patients with functional dyspepsia","volume":"13","author":"Ly","year":"2015","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1159\/000505810","article-title":"The brain-gut team","volume":"38","author":"Malagelada","year":"2020","journal-title":"Dig. Dis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/s0889-8553(03)00019-0","article-title":"Overview of functional gastrointestinal disorders: Dysfunction of the brain\u2013gut axis","volume":"32","author":"Mertz","year":"2003","journal-title":"Gastroenterol. Clin."},{"key":"B24","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1038\/ajg.2017.154","article-title":"ACG and CAG clinical guideline: Management of dyspepsia","volume":"112","author":"Moayyedi","year":"2017","journal-title":"Am. J. Gastroenterol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"77","DOI":"10.4166\/kjg.2019.73.2.77","article-title":"Functional dyspepsia","volume":"73","author":"Oh","year":"2019","journal-title":"Korean J. Gastroenterol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"29","DOI":"10.5056\/jnm19209","article-title":"Clinical practice guidelines for functional dyspepsia in Korea","volume":"26","author":"Oh","year":"2020","journal-title":"J. Neurogastroenterol. Motil."},{"key":"B27","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.dld.2011.10.009","article-title":"Natural history of functional gastrointestinal disorders: Comparison of two longitudinal population-based studies","volume":"44","author":"Olafsdottir","year":"2012","journal-title":"Dig. Liver Dis."},{"key":"B28","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: An updated guide-line for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1111\/j.1440-1746.2009.05934.x","article-title":"Chinese herbal medicine modified Xiaoyao san for functional dyspepsia: meta-analysis of randomized controlled trials","volume":"24","author":"Qin","year":"2009","journal-title":"J. Gastroenterol. Hepatol."},{"key":"B30","first-page":"398","article-title":"Effect of modified Xiaoyao powder on electrogastrographic picture and pharmacokinetic characteristics of ferulic acid in patients with functional dyspepsia of gan-qi stagnation with pi-deficiency syndrome type","volume":"26","author":"Ren","year":"2006","journal-title":"Chin. J. Integr. Tradit. West Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1053\/j.gastro.2016.02.011","article-title":"Gastroduodenal disorders","volume":"150","author":"Stanghellini","year":"2016","journal-title":"Gastroenterol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1056\/NEJMra1501505","article-title":"Functional dyspepsia","volume":"373","author":"Talley","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.1111\/j.1572-0241.1999.01363.x","article-title":"Validity of a new quality of life scale for functional dyspepsia: A United States multicenter trial of the nepean dyspepsia Index","volume":"94","author":"Talley","year":"1999","journal-title":"Am. J. Gastroenterol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"695","DOI":"10.16448\/j.cjtcm.2019.0205","article-title":"Meta analysis of the therapeutic effect of Xiaoyao Powder on functional dyspepsia","volume":"31","author":"Tang","year":"2019","journal-title":"Clin. J. Trad. Chin. Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/ajg.2016.499","article-title":"Pathophysiological abnormalities in functional dyspepsia subgroups according to the Rome III Criteria","volume":"112","author":"Vanheel","year":"2017","journal-title":"Am. J. Gastroenterol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"23","DOI":"10.13913\/j.cnki.41-1110\/r.2014.05.014","article-title":"Modified Xiaoyao san in the treatment of 52 cases of functional dyspepsia with Disharmony of Liver and Stomach","volume":"29","author":"Wang","year":"2014","journal-title":"Forum Trad. Chin. Med."},{"key":"B37","volume-title":"WHO international standard terminologies on traditional medicine in the Western Pacific Region","year":"2007"},{"key":"B38","volume-title":"Clinical observation of Xiaoyao san on functional dyspepsia","author":"Wu","year":"2014"},{"key":"B39","first-page":"302","article-title":"The randomized control clinical research of modified Xiaoyaosan on treatment of functional dyspepsia after operation of liver and gall bladder","volume":"22","author":"Xu","year":"2007","journal-title":"West China Med. J."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.3390\/molecules23051073","article-title":"Xiaoyaosan improves depressive-like behaviors in mice through regulating apelin-APJ system in hypothalamus","volume":"23","author":"Yan","year":"2018","journal-title":"Molecules"},{"key":"B41","doi-asserted-by":"publisher","first-page":"284","DOI":"10.3389\/fphar.2020.00284","article-title":"An integrated pharmacology-based analysis for antidepressant mechanism of Chinese herbal formula Xiao-Yao-San","volume":"11","author":"Yuan","year":"2020","journal-title":"Front. Pharmacol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"931636","DOI":"10.1155\/2012\/931636","article-title":"Chinese herbal formula xiao yao san for treatment of depression: A systematic review of randomized controlled trials","volume":"2012","author":"Zhang","year":"2012","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"902516","DOI":"10.1155\/2014\/902516","article-title":"Xiao Yao San improves depressive-like behavior in rats through modulation of \u03b2-arrestin 2-mediated pathways in hippocampus","volume":"2014","author":"Zhu","year":"2014","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"108621","DOI":"10.1016\/j.biopha.2019.108621","article-title":"Xiaoyaosan improves depressive-like behavior in rats with chronic immobilization stress through modulation of the gut microbiota","volume":"112","author":"Zhu","year":"2019","journal-title":"Biomed. Pharmacother."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1114222\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T05:54:19Z","timestamp":1681278859000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1114222\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,12]]},"references-count":44,"alternative-id":["10.3389\/fphar.2023.1114222"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2023.1114222","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,12]]},"article-number":"1114222"}}